Back to Journals » Journal of Multidisciplinary Healthcare » Volume 17

Response to Research Trends of Rheumatoid Arthritis and Depression [Letter]

Authors Agussalim , Yuniritha E , Nugroho HSW 

Received 25 September 2024

Accepted for publication 3 October 2024

Published 11 October 2024 Volume 2024:17 Pages 4743—4744

DOI https://doi.org/10.2147/JMDH.S497920

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser



Agussalim,1 Eva Yuniritha,2 Heru Santoso Wahito Nugroho3

1Parepare School of Nursing, Makassar Health Polytechnic, Makassar City, South Sulawesi Province, Indonesia; 2Padang School of Nutritionist, Padang Health Polytechnic, Padang City, West Sumatera Province, Indonesia; 3Center of Excellence, Surabaya Health Polytechnic, Surabaya City, East Java Province, Indonesia

Correspondence: Agussalim, Email [email protected]


View the original paper by Dr Zhao and colleagues

A Response to Letter has been published for this article.


Dear editor

After careful reading of the research article “Research Trends of Rheumatoid Arthritis and Depression from 2019 to 2023: A Bibliometric Analysis” written by Yan Zhao et al1 published in the Journal of Multidisciplinary Healthcare, we conclude that this study is good because it makes a significant contribution to understanding the relationship between RA and depression, as well as paving the way for further research. In addition, this study also provides a comprehensive overview of trends and bibliometric analysis, and this study focuses on quality of life and comorbidities.

In addition to the advantages mentioned above, it turns out that there are disadvantages of this study, including showing that international collaboration is still limited, especially between researchers from different countries. This can hinder the exchange of ideas and knowledge that is important for research progress. According to Kompas News, research collaboration between countries will greatly help develop research, education and technology in a country.2 In addition, according to Patricia Mcclunie-Trust et al, combining the knowledge and skills of like-minded researchers across tertiary education settings and international borders and research collaborations have the potential to increase research capacity for both individuals and the team alike.3 In addition, many studies conducted are cross-sectional, which may not provide a deep understanding of the causal relationship between RA and depression. Longitudinal research may be necessary to gain better insights. Cai et al4 in their study used a longitudinal tracking method to confirm the group heterogeneity of patient-reported outcomes, which provides guidance for medical staff to implement staged and individualized health interventions for COPD patients and facilitates the implementation of dynamic health assessment for the health low-level group of stable COPD patients. Their study provided the implementation of dynamic health assessment and timely nursing interventions based on the results of self-assessment and promoted their recovery.

Overall, although this study shows continued interest in the relationship between RA and depression, there are still many areas that need further research to improve the understanding and management of this condition.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Yan Z, Chen G-Y, Fang M, et al. Research trends of rheumatoid arthritis and depression from 2019 to 2023: a bibliometric analysis. J Multidiscip Healthc. 2024;17:4465–4474. doi:10.2147/JMDH.S478748

2. Kompas News. Pursuing Collaborative Research, 2021. Available from: https://www.kompas.id/baca/dikbud/2021/02/19/mengupayakan-riset-kolaboratif/. Accessed October 04, 2024.

3. Donaldson A, Mcclunie-Trust P, Jones V, Winnington R, Shannon K, Macdiarmid R. Doing case study research collaboratively: the benefits for researchers. Int J Qual Methods. 2022. doi:10.1177/16094069221096296

4. Cai M, Cui M, Nong Y, Qin J, Mo S. A longitudinal study of trajectories and factors influencing patient-reported outcomes in chronic obstructive pulmonary disease. Int J Chronic Obstr. 2022;17:2945–2956. doi:10.2147/COPD.S374129

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, 3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.